The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cardiff Oncology Inc’s current trading price is -35.20% away from its 52-week high, while its distance from the 52-week low is 155.21%. The stock’s price range for this period has been between $1.63 and $6.42 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.0 million for the day, a number notably lower than the average daily volume of 2.07 million over the last three months.
Cardiff Oncology Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $6.42 on 03/25/24, while the lowest price for the same period was registered at $1.63 on 02/13/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cardiff Oncology Inc (CRDF) has experienced a quarterly rise of 1.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 276.71M and boasts a workforce of 32 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.29, with a change in price of +1.62. Similarly, Cardiff Oncology Inc recorded 1,591,537 in trading volume during the last 100 days, posting a change of +63.78%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRDF stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
CRDF Stock Stochastic Average
Cardiff Oncology Inc’s raw stochastic average for the past 50 days is presently 56.22%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 57.60%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 73.63% and 80.70%, respectively.
CRDF Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -4.15%. However, over the last six months, the performance has been weaker by 74.79%. The price of CRDF increased 15.24% over the last 30 days. And in the last five days, it has fallen by -2.58%.
